(Q38568681)

4 September 2017

Expansion, purification, and functional assessment of human peripheral blood NK cells (English)

1 reference

4 September 2017

Srinivas S Somanchi

1

1 reference

4 September 2017

Vladimir V Senyukov

series ordinal

2

1 reference

4 September 2017

Cecele J Denman

series ordinal

3

1 reference

4 September 2017

Dean A Lee

series ordinal

4

1 reference

4 September 2017

language of work or name

1 reference

2 February 2011

1 reference

Journal of Visualized Experiments

4 September 2017

1 reference

4 September 2017

48

1 reference

4 September 2017

20

1 reference

Expansion of highly cytotoxic human natural killer cells for cancer cell therapy

4 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180743

Replicative potential of human natural killer cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180743

Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180743

Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180743

Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180743

Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180743

Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180743

Ex vivo expansion of natural killer cells for clinical applications.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3180743

A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21339714

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activation

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21339714

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ex vivo expansion of natural killer cells with high cytotoxicity by K562 cells modified to co-express major histocompatibility complex class I chain-related protein A, 4-1BB ligand, and interleukin-15

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21339714

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3791/2540

1 reference

4 September 2017

1 reference

4 September 2017

1 reference